Overview
Dr. Margaret 'Maggie' Cupit-Link is a pediatric hematologist/oncologist who treats patients from birth to 23 years old. She diagnoses, treats, and provides supportive care for patients with pediatric cancers; pediatric solid tumors; sarcomas; and neuroblastoma. Dr. Cupit-Link studies acute and chronic toxicities from pediatric cancer therapies; late effects of pediatric cancer immunotherapy; late effects of anti-GD2 antibody; onco-fertility; and quality of life in pediatric cancer patients and survivors. Her clinical research aims to understand and reduce acute and long-term toxicities from pediatric cancer therapies. A cancer survivor herself, Dr. Cupit-Link deeply cares for her patients, employing empathy and compassion to support them and lessen their suffering. Dr. Cupit-Link is an assistant professor with the Division of Pediatrics - Hematology/Oncology in the Department of Pediatrics at Saint Louis University School of Medicine. She is a member of the American Society of Pediatric Hematology/Oncology; Children's Oncology Group; and American Society of Clinical Oncology.
Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Immune Thrombocytopenic Purpura (ITP).
Dr. Cupit-Link is board certified in American Board Of Pediatrics , Missouri Dept Of Health/Narcotics&Dangerous Drugs , Missouri State Board Of Registration, and Drug Enforcement Administration . She is actively involved in clinical research, co-authoring 1 peer reviewed article. Dr. Cupit-Link is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
1465 S. Grand Blvd., St. Louis, MO 63104
Additional Areas of Focus
Dr. Cupit-Link has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
St. Louis Children's Hospital
Melanie Fields is a Hematologist and an Oncologist practicing medicine in Saint Louis, Missouri. Dr. Fields is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Fields is currently accepting new patients.
St. Louis Children's Hospital
Joshua Rubin is a Hematologist and an Oncologist practicing medicine in Saint Louis, Missouri. Dr. Rubin is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Glioma, Brain Tumor, Gliomatosis Cerebri, Glioblastoma, and Orchiectomy. Dr. Rubin is currently accepting new patients.
Washington University School Of Medicine
Brad Kahl is a Hematologist practicing medicine in Saint Louis, Missouri. Dr. Kahl is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Follicular Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kahl is currently accepting new patients.
Frequently Asked Questions about Dr. Maggie C. Cupit-Link
How do I make an appointment with Dr. Maggie C. Cupit-Link?
You can book an appointment with Dr. Maggie C. Cupit-Link by calling their office at 314-268-4000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Maggie C. Cupit-Link a top-rated expert for Neuroblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Maggie C. Cupit-Link is classified as an Experienced expert for Neuroblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Maggie C. Cupit-Link specialize in?
While Dr. Maggie C. Cupit-Link is a Hematology, they have specific expertise in Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Immune Thrombocytopenic Purpura (ITP). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Maggie C. Cupit-Link participate in research or clinical trials?
Yes. Dr. Maggie C. Cupit-Link has published 1 articles and abstracts on conditions like Neuroblastoma. You can view a list of Dr. Maggie C. Cupit-Link's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Maggie C. Cupit-Link accept my insurance?
Dr. Maggie C. Cupit-Link accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-268-4000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Embryonal Tumor with Multilayered RosettesDr. Cupit-Link isExperienced. Learn about Embryonal Tumor with Multilayered Rosettes.
- NeuroblastomaDr. Cupit-Link isExperienced. Learn about Neuroblastoma.